Vitrafy Life Sciences Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	12.72	19.52	6.41	1.72	0.96
Short-Term Investments	10.08	0.05	0.04	0.04	0.02
Cash & Short-Term Investments	22.8	19.57	6.45	1.76	0.98
Cash Growth	-33.82%	203.32%	266.56%	78.74%	-
Accounts Receivable	0.36	0.06	0.03	0.03	-
Other Receivables	-	1.55	2.17	2.11	1.94
Receivables	0.36	1.61	2.2	2.14	1.94
Prepaid Expenses	-	-	0.38	-	-
Other Current Assets	-	10.08	-	-	0.56
Total Current Assets	23.15	31.25	9.03	3.9	3.49
Property, Plant & Equipment	0.53	0.59	0.75	1.03	0.88
Total Assets	23.68	31.84	9.78	4.93	4.37
Accounts Payable	1.11	0.56	0.27	0.44	0.24
Accrued Expenses	0.28	0.43	0.43	0.32	0.23
Short-Term Debt	-	-	22.86	8.55	7.5
Current Portion of Leases	0.09	0.09	0.08	0.09	0.07
Current Unearned Revenue	0.24	1.43	-	-	-
Other Current Liabilities	-	0.21	10.31	9.55	3.23
Total Current Liabilities	1.72	2.72	33.95	18.95	11.26
Long-Term Leases	0.25	0.3	0.39	0.54	0.34
Pension & Post-Retirement Benefits	0.06	0.05	0.03	0.07	0.04
Total Liabilities	2.03	3.08	34.38	19.56	11.64
Common Stock	89.69	89.69	5.19	4.92	4.83
Retained Earnings	-70.49	-60.92	-29.79	-20.23	-12.42
Comprehensive Income & Other	2.46	-	-	0.68	0.32
Shareholders' Equity	21.65	28.77	-24.6	-14.63	-7.27
Total Liabilities & Equity	23.68	31.84	9.78	4.93	4.37
Total Debt	0.35	0.39	23.33	9.19	7.91
Net Cash (Debt)	22.45	19.18	-16.88	-7.43	-6.93
Net Cash Per Share	0.35	0.43	-5.50	-2.52	-2.37
Filing Date Shares Outstanding	63.85	63.85	3.12	2.98	2.93
Total Common Shares Outstanding	63.85	63.85	3.12	2.98	2.93
Working Capital	21.44	28.53	-24.92	-15.05	-7.77
Book Value Per Share	0.34	0.45	-7.90	-4.91	-2.48
Tangible Book Value	21.65	28.77	-24.6	-14.63	-7.27
Tangible Book Value Per Share	0.34	0.45	-7.90	-4.91	-2.48
Machinery	-	0.75	0.74	0.73	0.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.